I heard a justification of all this at the EGM by phil daffis, made me confident of their plan, and with a guy who was VP of marketing at Cochlear I reckon he knows more than I do...don't forget they have noted a milestone of a commercial product in the dementia industry back end of 2017. Revenue is thus expected, they have clearly stated the milestones they aim to achieve for commercialisation, I read an annual report of another company this week which was scarce on timing for their commercial product. I think a point will come where the market will click that EPT isn't that far away from being commercial with a product .
- Forums
- ASX - By Stock
- Ann: Change of Company Name-MNQ.AX
I heard a justification of all this at the EGM by phil daffis,...
-
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MNQ (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online